DEFINING TARGETS FOR ANTIFUNGAL STEWARDSHIP IN IMMUNOCOMPROMISED PATIENTS

Abstract

Patients with impaired immune systems are at risk of serious fungal infections. Antifungal medicines used to prevent and treat these infections can be toxic and costly. This project aims to review current antifungal use and improvement activities in place in health services, assess prescriber knowledge, and to evaluate current doses of echinocandin antifungals used in liver failure patients. This project will identify ways to improve antifungal use needed for effective and safe prescribing.

Related publications (2)

Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity

JC Kwong, K Urbancic, JA Trubiano

2018-12-01

Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients

Karen F Urbancic, Daisy Pisasale, Joel Wight, Jason A Trubiano

2018-12-01